Purnima S. Teegavarapu
Expertise in
3
conditions

Dr. Purnima S. Teegavarapu

Oncology | Hematology
1919 Old Spanish Trail, 6th Floor, 
Houston, TX 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
3
conditions
1919 Old Spanish Trail, 6th Floor, 
Houston, TX 

Overview

Dr. Sravanti Teegavarapu specializes in benign and malignant hematological diseases. She is an Assistant Professor of Medicine - Hematology and Oncology and Medical Director of Hematology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Teegavarapu’s clinical interests include lymphomas and other blood diseases. Dr. Teegavarapu received her medical degree from the Armed Forces Medical College in Pune, India.She completed her residency at University of North Dakota in Fargo and postdoctoral fellowship at the M.D. Anderson Cancer Center in Houston. She also completed a fellowship at Houston Methodist Hospital/Weill Cornell Medical College.Dr. Teegavarapu is board-certified by the American Board of Internal Medicine, American Board of Hematology and the American Board of Oncology. In addition to English, Dr. Teegavarapu speaks Telugu and Hindi.

Dr. Teegavarapu is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Diffuse Large B-Cell Lymphoma (DLBCL), and Large-Cell Immunoblastic Lymphoma.

She is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 1 clinical trial. Dr. Teegavarapu is currently accepting new patients.

Specialties

Oncology
Hematology

Licenses

Internal Medicine in TX

Fellowships

Fellowship at Houston Methodist Hospital/Weill Cornell Medical College Houston
Postdoctoral Fellowship at University of Texas MD Anderson Cancer Center Houston

Hospital Affiliations

Baylor St Lukes Medical Center
Harris Health
Baylor St. Luke's Medical Center - Houston, TX

Languages Spoken

English
Hindi
Telugu

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

1919 Old Spanish Trail, 6th Floor, Houston, TX 77054

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Phase 1/2 Study of Selinexor in Combination With Backbone Treatments or Novel Therapies in Patients With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
A Multicenter, Phase 1/2 Study of Selinexor in Combination With Backbone Treatments or Novel Therapies in Patients With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment Status: Withdrawn
Publish Date: October 03, 2025
Intervention Type: Drug
Study Drugs: Selinexor, Rituximab, Bendamustine, Polatuzumab Vedotin, Ibrutinib, Lenalidomide, Tafasitamab, Venetoclax, Gemcitabine, Oxaliplatin
Study Phase: Phase 1/Phase 2

6 Total Publications

Clinical Outcomes and Patterns of Care Among Patients With Newly Diagnosed Classical Hodgkin Lymphoma in a Safety-Net Health System.
Clinical Outcomes and Patterns of Care Among Patients With Newly Diagnosed Classical Hodgkin Lymphoma in a Safety-Net Health System.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 12, 2025
Similar Doctors
Expertise in
27
conditions
Dr. William G. Wierda
Hematology | Oncology
Expertise in
27
conditions
Dr. William G. Wierda
Hematology | Oncology
Referral may be required

University Of Texas MD Anderson Cancer Center

1515 Holcombe Blvd Unit 428, 
Houston, TX 
 (1.8 miles away)
713-792-7040
Languages Spoken:
English
See accepted insurances

William Wierda is a Hematologist and an Oncologist practicing medicine in Houston, Texas. Dr. Wierda is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Expertise in
12
conditions
Dr. Carl E. Allen
Hematology | Oncology
Expertise in
12
conditions
Dr. Carl E. Allen
Hematology | Oncology
Referral may be required

Office

1102 Bates Ave Ste 750, 
Houston, TX 
 (1.8 miles away)
832-824-4312
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carl Allen is a Hematologist and an Oncologist practicing medicine in Houston, Texas. Dr. Allen is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant. Dr. Allen is currently accepting new patients.

Expertise in
21
conditions
Dr. Murali M. Chintagumpala
Hematology | Oncology
Expertise in
21
conditions
Dr. Murali M. Chintagumpala
Hematology | Oncology
Referral may be required

Baylor College Of Medicine

6701 Fannin St, 
Houston, TX 
 (1.9 miles away)
832-822-4242
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Murali Chintagumpala is a Hematologist and an Oncologist practicing medicine in Houston, Texas. Dr. Chintagumpala is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Gliomatosis Cerebri, Brain Tumor, Posterior Fossa Tumor, and Nephrectomy. Dr. Chintagumpala is currently accepting new patients.

Frequently Asked Questions about Dr. Purnima S. Teegavarapu

How do I make an appointment with Dr. Purnima S. Teegavarapu?

You can book an appointment with Dr. Purnima S. Teegavarapu by calling their office at 832-957-6500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Purnima S. Teegavarapu a top-rated expert for Schnitzler Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Purnima S. Teegavarapu is classified as an Advanced expert for Schnitzler Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Purnima S. Teegavarapu specialize in?

While Dr. Purnima S. Teegavarapu is a Oncology, they have specific expertise in Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Diffuse Large B-Cell Lymphoma (DLBCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Purnima S. Teegavarapu participate in research or clinical trials?

Yes. Dr. Purnima S. Teegavarapu has published 6 articles and abstracts on conditions like Schnitzler Syndrome. You can view a list of Dr. Purnima S. Teegavarapu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Purnima S. Teegavarapu accept my insurance?

Dr. Purnima S. Teegavarapu accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 832-957-6500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Teegavarapu's expertise for a condition
ConditionClose
      View All 40 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile